Copyright
©The Author(s) 2021.
World J Transplant. May 18, 2021; 11(5): 138-146
Published online May 18, 2021. doi: 10.5500/wjt.v11.i5.138
Published online May 18, 2021. doi: 10.5500/wjt.v11.i5.138
Disease | Ref. | Model | Delivery route | Results |
Myocardial infarction | Kocher et al[24] | Animal | Intravenous | (+) Angiogenesis; (-) Cardiomyocyte apoptosis, collagen deposition, scar formation |
Kawamoto et al[25] | Human | Intramyocardial | (+) Angiogenesis, cardiac function; (-) Myocardial fibrosis | |
Botta et al[26] | Animal | Intramyocardial | (+) Cardiac function; (+) Cardiac hemodynamics with CD34+ KDR+ subset | |
Brenner et al[27] | Animal | Intracavitary of LV | (+) LV function | |
Ott et al[28] | Animal | Intramyocardial | (+) LVEF | |
Yoshioka et al[29] | Human | Intracardiac | (+) Blood flow; (+) Cardiac function | |
Shintani et al[30] | Animal | Intramyocardial | (+) Capillary density; (-) Myocardial infarct size | |
Zhang et al[31] | Animal | Intracoronary | (+) Cardiac repair, therapeutic benefits | |
Wang et al[32] | Animal | Intramyocardial | (+) Angiogenesis, cardiac function | |
Mackie et al[33] | Animal | Intramyocardial | (+) Capillary density; (-) Ventricular dilation, infarct size, cardiac function alteration | |
Joladarashi et al[34] | Animal | Intramyocardial | (+) Angiogenesis; (-) LV remodeling and cardiac fibrosis with CD34 deficient microRNA 377 | |
Quyyumi et al[38] | Human | Intracoronary | (+) LVEF; (-) Infarct size and MACE | |
Quyyumi et al[40] | Human | Intracoronary | (+) Infarcted area perfusion | |
Refractory angina | Losordo et al[43] | Human | Intramyocardial | (+) Exercise tolerance; (-) Angina frequency, 12 mo mortality |
Henry et al[45] | Human | Intramyocardial | (-) Angina frequency at 2 yr | |
Povsic et al[46] | Human | Intramyocardial | (-) Angina frequency | |
Wang et al[47] | Human | Intramyocardial | (+) Myocardial perfusion by PET; (-) Angina frequency | |
Lee et al[48] | Human | Intracoronary | (+) LVEF; (-) Angina frequency | |
Johnson et al[49] | Human | Intramyocardial | (-) Mortality, cardiac admissions, hospital visits, health care costs | |
Heart failure (dilated cardiomyopathy) | Vrtovec et al[50] | Human | Intracoronary | (+) LVEF, 6MWD; (-) NT-proBNP, mortality |
Lezaic et al[51] | Human | Intracoronary | (+) Myocardial perfusion, LVEF, 6MWD | |
Bervar et al[53] | Human | Transendocardial | (+) 6MWD, diastolic function; (-) NT-proBNP | |
Poglajen et al[54] | Human | Transendocardial | (+) 6MWD, LVEF; (-) NT-proBNP | |
Coronary microvascular dysfunction | Erbs et al[17] | Human | Intracoronary | (+) CFR |
Schächinger et al[18] | Human | Intracoronary | (+) CFR |
- Citation: Matta A, Nader V, Galinier M, Roncalli J. Transplantation of CD34+ cells for myocardial ischemia. World J Transplant 2021; 11(5): 138-146
- URL: https://www.wjgnet.com/2220-3230/full/v11/i5/138.htm
- DOI: https://dx.doi.org/10.5500/wjt.v11.i5.138